Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
b43-genistein immunoconjugate (1 trial)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Lymphoma (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Trials (1 total)
Trial APIs (1 total)